Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
已完结
10
由 达姆 发布于 2025/11/25 9:42:39
DOI:10.1016/S0140-6736(16)32389-3
作者：J. Robertson,?I. Bondarenko,?E. Trishkina,?M. Dvorkin,?L. Panasci,?A. Manikhas,?Y. Shparyk,?S. Cardona-Huerta,?K. Cheung,?M. Philco-Salas,?M. Ruiz-Borrego,?Z. Shao,?S. Noguchi,?J. Rowbottom,?M. Stuart
文献类型：期刊论文
补充材料：只需要正文
作者：J. Robertson,?I. Bondarenko,?E. Trishkina,?M. Dvorkin,?L. Panasci,?A. Manikhas,?Y. Shparyk,?S. Cardona-Huerta,?K. Cheung,?M. Philco-Salas,?M. Ruiz-Borrego,?Z. Shao,?S. Noguchi,?J. Rowbottom,?M. Stuart
文献类型：期刊论文
补充材料：只需要正文
Elsevier
其它数据库
京公网安备 11010802042870号
